Featured Research

from universities, journals, and other organizations

New flu strains prompt review of current research, call to redouble flu fight

Date:
May 29, 2013
Source:
American Physiological Society (APS)
Summary:
New flu strains prompt review of current research and a call to redouble the flu fight.

Despite numerous medical advances over the past century, the flu -- a seasonal rite of passage for many around the world -- still remains deadly and dangerous. An estimated 150,000 to 200,000 are hospitalized from influenza annually just in the United States, and between 30,000 to 50,000 die from this infection. The flu takes a heavy financial toll as well, leading countries to lose billions in direct medical costs, loss of productivity, and loss of life. In April of this year, a new flu strain known as H7N9, thought to have the potential to cause a pandemic, emerged in China. This novel strain's high mortality rate, more than 20 percent, has led the Centers for Disease Control and Prevention to issue predictions of hospitalizations, deaths, and economic impacts several times higher than those caused by the typical seasonal flu.

In light of this new information, researchers have published a comprehensive overview of current flu research and efforts to combat this potentially lethal disease, including global surveillance to track the flu and vaccines and antiviral drugs currently in use. They also issue a call to improve efforts to fight the flu, including improving surveillance, developing new types of vaccines and drugs, and -- most importantly -- improving efforts to educate the public about the flu. This review article, entitled "Adapting global influenza management strategies to address emerging viruses" is published online by the American Journal of Physiology-Lung Cellular and Molecular Physiology.

The new article is written by Diana L. Noah and James W. Noah, both of the Southern Research Institute.

Fighting Flu Now In their review, the researchers explain that various strains of the flu circulate annually, with new strains arising through small mutations in current strains and others arising spontaneously. Of these, several H7 strains -- so named for a portion of the virus called hemagglutinin -- have caused flu outbreaks in various parts of the world. For the most part, these infectious have caused mild upper respiratory symptoms. However, as the authors' review was completed, the130 known H7N9 infections had caused 31 fatalities -- a morality rate of more than 20 percent.

Though the transmission mode of the strain is not yet known, some research suggests that H7N9 is being passed between humans, rather than from animals to humans, a dangerous sign that this outbreak has the potential to escalate into a deadly pandemic.

The authors point out that the best way to curb flu deaths is by preventing the disease altogether through vaccination. However, many countries, including the United States, have suboptimal flu vaccination rates. Even if more people got the flu shot, they write, the vaccine itself isn't perfect -- although each year's flu vaccine has been crafted to inspire an immune response to several different flu strains, it's not always a match to currently circulating strains.

Because the flu mutates each year, researchers must develop a new vaccine annually. But when surveillance efforts identify dangerous strains, the authors say, current manufacturing efforts may not be able to produce new vaccines quickly enough to protect a large population.

For those who have the bad luck of contracting the flu, antivirals are currently available to limit disease severity and shorten its duration. However, the review authors say, the antiviral drugs currently in use are increasingly becoming less effective due to the flu's ability to constantly mutate.

Flu in the Future To better combat the flu, Noah and Noah review a number of current efforts. For example, they say, a universal vaccine that could fight any flu strain and still be useful year after year is in development. Also, several companies are now working on new ways to manufacture current flu vaccines more quickly to avoid the problem of a vaccine shortage in the face of a rapidly arising pandemic. Other companies are focusing on developing new antivirals to gain the upper hand on flu strains that are immune to current drugs, as well as other drugs that modulate the human host's immune response to the flu, which researchers now know can cause as much or more damage as the virus itself.

With a call to support each of these efforts, the authors point out that educating the public about the flu is equally important. Outreach efforts to increase public awareness, hygiene practices, and vaccination rates could significantly stem flu deaths, they say.

"Key innovations that result in new antivirals and new, broadly effective vaccines will contribute to increased public health, but aggressive education programs may be the most important factor in immediately leveraging current vaccines and antivirals," they write.


Story Source:

The above story is based on materials provided by American Physiological Society (APS). Note: Materials may be edited for content and length.


Journal Reference:

  1. D. L. Noah, J. W. Noah. Adapting Global Influenza Management Strategies to Address Emerging Viruses.. AJP: Lung Cellular and Molecular Physiology, 2013; DOI: 10.1152/ajplung.00105.2013

Cite This Page:

American Physiological Society (APS). "New flu strains prompt review of current research, call to redouble flu fight." ScienceDaily. ScienceDaily, 29 May 2013. <www.sciencedaily.com/releases/2013/05/130529121009.htm>.
American Physiological Society (APS). (2013, May 29). New flu strains prompt review of current research, call to redouble flu fight. ScienceDaily. Retrieved July 29, 2014 from www.sciencedaily.com/releases/2013/05/130529121009.htm
American Physiological Society (APS). "New flu strains prompt review of current research, call to redouble flu fight." ScienceDaily. www.sciencedaily.com/releases/2013/05/130529121009.htm (accessed July 29, 2014).

Share This




More Health & Medicine News

Tuesday, July 29, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Generics Eat Into Pfizer's Sales

Generics Eat Into Pfizer's Sales

Reuters - Business Video Online (July 29, 2014) Pfizer, the world's largest drug maker, cut full-year revenue forecasts because generics could cut into sales of its anti-arthritis drug, Celebrex. Fred Katayama reports. Video provided by Reuters
Powered by NewsLook.com
Nigeria Ups Ebola Stakes on 1st Death

Nigeria Ups Ebola Stakes on 1st Death

Reuters - Business Video Online (July 29, 2014) Nigerian authorities have shut and quarantined a Lagos hospital where a Liberian man died of the Ebola virus, the first recorded case of the highly-infectious disease in Africa's most populous economy. David Pollard reports Video provided by Reuters
Powered by NewsLook.com
Running 5 Minutes A Day Might Add Years To Your Life

Running 5 Minutes A Day Might Add Years To Your Life

Newsy (July 29, 2014) According to a new study, just five minutes of running or jogging a day could add years to your life. Video provided by Newsy
Powered by NewsLook.com
Ebola Outbreak Poses Little Threat To U.S.: CDC

Ebola Outbreak Poses Little Threat To U.S.: CDC

Newsy (July 29, 2014) The Ebola outbreak in West Africa poses little threat to Americans, according to officials with the Centers for Disease Control and Prevention. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins